1887

Abstract

A point mutation at nucleotide 5233 of the polyomavirus (A2 strain) enables it to overcome growth restriction in undifferentiated embryonal carcinoma cells. We analysed the binding of nuclear proteins from F9 cells to a 38 bp region that spans this site of mutation and encompasses two copies of the bovine papillomavirus core sequence, CCACCC, and characterized this domain by mutational analysis. Our results showed that the F441 mutation creates a sequence motif which binds TEF-1 or a TEF-1-like protein from F9 cells more strongly than its wild-type counterpart and increases its activity by about 10-fold. Another protein identified as CP1 binds with increased affinity in the presence of the F441 mutation to the CAT box-like sequences which is contiguous with the downstream CCACCC box. Point mutations within these two motifs that abolished binding also impaired the activity of the F441 locus . As neither the wild-type sequence without the F441 mutation, nor the F441 template without the CAT box has appreciable activity , interaction between these two elements is required for function. At a higher level of organization, this interaction is probably extended to factors bound to other domains in the A and B enhancer.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-4-597
1993-04-01
2024-04-30
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/4/JV0740040597.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-4-597&mimeType=html&fmt=ahah

References

  1. Amati P. 1985; Polyoma regulatory region: a potential probe for mouse cell differentiation. cell 43:561–562
    [Google Scholar]
  2. Bohnlein E., Chowdhury K., Gruss P. 1985; Functional analysis of the regulatory region of polyoma mutant F9-1 DNA. Nucleic Acids Research 13:4789–4809
    [Google Scholar]
  3. Bradford M. M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
    [Google Scholar]
  4. Chakraborty T., Das G. C. 1989; Identification of HeLa cell nuclear factors that bind to and activate human polyomavirus BK in vitro. Molecular and Cellular Biology 9:3821–3827
    [Google Scholar]
  5. Chodosh L. A., Baldwin A. S., Carthew R. W., Sharp P. A. 1988; Human CCAAT binding proteins have heterologous subunits. Cell 53:11–24
    [Google Scholar]
  6. Cohen R. B., Sheffrey M., Kim C. G. 1989; Partial purification of a nuclear protein that binds to the CAAT box of the mouse alpha-1-globin gene. Molecular and Cellular Biology 6:821–832
    [Google Scholar]
  7. Davidson I., Xiao J. X, Rosales R., Staub A., Chambon P. 1988; The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Cell 54:931–942
    [Google Scholar]
  8. Dignam J. D, Lebovitz R. M., Roeder R. G. 1983; Accurate transcription by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Research 11:1475–1489
    [Google Scholar]
  9. Fromental C., Kanno M., Nomiyama H., Chambon P. 1988; Cooperativity and hierarchical levels of functional organization in the SV40 enhancer. Cell 54:943–953
    [Google Scholar]
  10. Fujimura F. K., Deininger P. L., Freidmann T., Linney E. 1981; Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells. Cell 23:809–814
    [Google Scholar]
  11. Garner M. M., Revzin A. 1981; A gel electrophoresis method for quantifying binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Research 9:3047–3060
    [Google Scholar]
  12. Gorman C., Moffat L. F., Howard B. 1982; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
    [Google Scholar]
  13. Hen R., Borrelli E., Fromental C., Sassone-Corsi P., Chambon P. 1986; A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products. Nature, London 321:249–251
    [Google Scholar]
  14. Kovesdi I., Satake M., Furukawa K., Reichel R., Ito Y., Nevins J. R. 1987; A factor discriminating between the wild type and mutant polyoma virus enhancer. Nature, London 328:87–89
    [Google Scholar]
  15. Kryszke M. H., Piette J., Yaniv M. 1987; Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells. Nature, London 328:254–256
    [Google Scholar]
  16. Luckow B., Schutz G. 1987; CAT construction with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Research 15:5490
    [Google Scholar]
  17. Lusky M., Berg L., Weiher H., Botchan M. 1983; Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit. Molecular and Cellular Biology 3:1108–1122
    [Google Scholar]
  18. McQuillan J. J, Rosen G. D., Birkenmeier T. M., Dean D. 1991; Identification of a protein that interacts with the nuclear factor-1 (NF-1) binding site in cells that do not express NF-1: comparison to NF-1, cellular distribution and effect on transcription. Nucleic Acids Research 19:6627–6631
    [Google Scholar]
  19. Martin M. E., Piette J., Yaniv M., Tang W. J., Folk W. R. 1988; Activation of the polyomavirus enhancer by a murine activator protein (API) homolog and two contiguous proteins. Proceedings of the National Academy of Sciences, U.S.A. 85:5839–5843
    [Google Scholar]
  20. Nagata K., Guggenheimer R. A., Hurwitz J. 1983; Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA. Proceedings of the National Academy of Sciences, U.S.A. 80:6177–6181
    [Google Scholar]
  21. Ondek B., Gloss L., Herr W. 1988; The SV40 enhancer contains two distinct levels of organization. Nature, London 333:40–45
    [Google Scholar]
  22. Ostapchuk P., Scheirle G., Hearing P. 1989; Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region. Molecular and Cellular Biology 9:2787–2797
    [Google Scholar]
  23. Rosenfeld P. J., O’Neill E. A., Wides R. J., Kelly T. J. 1987; Sequence specific interactions between cellular DNA-binding proteins and the adenovirus origin of DNA replication. Molecular and Cellular Biology 7:875–886
    [Google Scholar]
  24. Satake M., Furukawa K., Ito Y. 1988; Biological activities of oligonucleotides spanning F9 point mutation within the enhancer region of polyomavirus DNA. Journal of Virology 62:970–977
    [Google Scholar]
  25. Speck N. A., Baltimore D. 1987; Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Molecular and Cellular Biology 1:1101–1111
    [Google Scholar]
  26. Swartzendruber D. E., Lehman J. M. 1975; Neoplastic differentiation: interaction of simian virus 40 and polyomavirus with murine teratocarcinoma cells in vitro. Journal of Cellular Physiology 85:179–188
    [Google Scholar]
  27. Tseng R. W., Fujimura F. K. 1988; Multiple domains in the polyomavirus B region are required for productive infection of F9 embryonal carcinoma cells. Journal of Virology 62:2890–2895
    [Google Scholar]
  28. Tseng R. W., Williams T., Fujimura F. K. 1988; Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells. Journal of Virology 62:2896–2902
    [Google Scholar]
  29. Xiao J. H, Davidson I., Matthes H., Garnier J. M., Chambon P. 1991; Cloning, expression, and transcriptional properities of the human enhancer factor TEF-1. Cell 65:551–568
    [Google Scholar]
  30. Yu C. Y., Motamed K., Chen J., Bailey A. D., Chen C. KJ. 1991; The CACC box upstream of human embryonic zeta globin gene binds Spl and is a functional promoter element in vitro and in vivo. Journal of Biological Chemistry 266:8907–8915
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-4-597
Loading
/content/journal/jgv/10.1099/0022-1317-74-4-597
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error